Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
724.87 | -45.65% | -23.35% | 654,235.43 | 0.71% | 3.59% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
866.80 | 3.46% | 24.94% | 3,864,579.71 | 1.07% | 18.25% |
|
NYSE:JNJ
Johnson & Johnson
|
146.82 | 0% | 0% | 356,431.01 | 3.34% | 3.91% |
|
NYSE:MRK
Merck
|
130.72 | -7.08% | 6.52% | 321,694.58 | 2.43% | -19.03% |
|
NYSE:ABBV
AbbVie
|
167.29 | -23.01% | -12.83% | 294,653.36 | 3.69% | 7.24% |
|
SWX:NOVN
Novartis
|
90.00 | 13.6% | 27.68% | 181,473.74 | 3.7% | 4.67% |
|
NYSE:ABT
Abbott Laboratories
|
106.86 | -0.62% | 11.74% | 186,150.57 | 2.06% | 9.04% |
|
NasdaqGS:AMGN
Amgen
|
269.38 | 1.95% | 12.18% | 144,247.48 | 3.3% | 5.31% |
|
NYSE:MDT
Medtronic
|
79.25 | 27.19% | 37.68% | 105,535.34 | 3.43% | 2.09% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.70 | 59.34% | 69.53% | 90,596.11 | 4.91% | 13.54% |
|
ASX:CSL
CSL
|
278.45 | 27.29% | 48.97% | 130,231.78 | 1.31% | 7.18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
65.27 | 22.12% | 31.5% | 81,389.69 | 4.59% | 0.15% |
|
LSE:GSK
GSK
|
16.41 | 19.26% | 36.94% | 65,336.14 | 3.55% | 0.4% |
|
XTRA:MRK
Merck KGaA
|
150.10 | 17.91% | 34.79% | 63,477.57 | 1.44% | 10.29% |
|
NYSE:BDX
Becton Dickinson and Co
|
230.48 | 16.51% | 30.74% | 67,637.79 | 1.63% | 2.09% |
|
TSE:4568
Daiichi Sankyo Company
|
4766.00 | 0% | 0% | 9,606,688.48 | 1.27% | 0% |
|
TSE:4519
Chugai Pharmaceutical
|
4860.00 | 0% | 0% | 8,475,012.18 | 1.59% | 0% |
|
NYSE:MMM
3M
|
91.41 | 84.09% | 103.49% | 50,582.75 | 6.56% | -2.45% |
|
XTRA:BAS
BASF
|
50.99 | 11.88% | 37.3% | 45,509.71 | 6.63% | -13.88% |
|
SWX:LONN
Lonza Group
|
513.80 | -27.63% | -12.41% | 37,702.55 | 0.77% | 0.68% |
